Literature DB >> 28281954

An Assessment of Direct Restorative Material Use in Posterior Teeth by American and Canadian Pediatric Dentists: I. Material Choice.

Rae E Varughese1, Paul Andrews2, Michael J Sigal3, Amir Azarpazhooh4.   

Abstract

PURPOSE: The purpose of this study was to assess the preferences of pediatric dentists in Canada and the United States about clinical decision-making related to the placement of direct restorative materials.
METHODS: A cross-sectional web-based survey was used to collect the preference of all active pediatric members of the Royal College of Dentists of Canada and the American Academy of Pediatric Dentistry on the use of direct restorative materials in posterior teeth in healthy, developmentally delayed (DD), and medically compromised (MC) children. Bivariate and multivariate analyses were performed to determine the association between the predictor variables and all materials at two-tailed P<0.05.
RESULTS: A response rate of 19.3 percent (n equals 762) was achieved. For DD patients, stainless steel crowns were the most preferred material for primary teeth, and a similar frequency of amalgam and composite were preferred for permanent teeth. Amalgam usage was increasingly preferred in the DD population versus healthy and MC patients.
CONCLUSIONS: Composite resin was the most preferred restoration for Class I, II, and V restorations in primary and permanent teeth in healthy and medically compromised individuals. In DD individuals, stainless steel crowns and amalgam were preferred more frequently.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28281954

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  1 in total

1.  Treatment decisions regarding caries and dental developmental defects in children - a questionnaire-based study among Norwegian dentists.

Authors:  M M Uhlen; H Valen; L S Karlsen; A B Skaare; A Bletsa; V Ansteinsson; A Mulic
Journal:  BMC Oral Health       Date:  2019-05-10       Impact factor: 2.757

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.